Study Site 20 — North Dartmouth, Massachusetts

Study Site 20 is a clinical research site located in North Dartmouth, Massachusetts, United States 02747.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Study Site 20 has participated in 1 clinical trials.

Therapeutic areas: Diabetes Mellitus, Type 2.

Sponsors: NovMetaPharma Co., Ltd..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Study Site 20?

Study Site 20 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Study Site 20 conducted?

Study Site 20 has 1 clinical trials on record. Their work covers Diabetes Mellitus, Type 2.

Is Study Site 20 accredited by Crixeo Health?

Study Site 20 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Study Site 20?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.